Experience the Conference at Your Leisure.


February 9 – 11th, 2022


Subscribe to Access Conference Videos & Presentations


AEIE 2022 Conference:

February 9 – 11th, 2022 

Autoimmune Encephalopathy Secondary to Infectious Disease: A New Perspective on the Pathogenetic Interaction of the Immune system, Infection, Stress and Chronic Disease

This program was jointly sponsored by the International Center for Interdisciplinary Studies of Immunology (ICISI) at Georgetown University Medical Center and The Foundation for Total Recovery.

Redefining the Problem of “Chronic Pain”

In the United States, over 70 million Americans suffer with debilitating diseases for which the diagnosis and treatment are highly controversial and/or largely ineffective (CDC Report, 2016). These diseases are generally classified under the broad term of “Chronic Pain.”

The Role of Immune-System Malfunctions

Increasing evidence suggests that the disease process in a number of controversial conditions like PANDAS/PANS, Postural Orthostatic Tachycardia Syndrome (POTS), Post Lyme Syndrome, Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS), as well as in more accepted chronic pain diagnoses such as Fibromyalgia, Complex Regional Pain Syndrome (CRPS), and psychiatric conditions — such as major depression, anxiety, or bipolar disease — are all driven by immune system malfunctions. Indeed, it is common for many of these diseases to be comorbid, further suggesting a common patholophysiologic process. There is early evidence of involvement of both the innate, as well as the acquired immune systems in all of these conditions. Given the complexity of these chronic pain conditions, it is not surprising that standard-of-care diagnostic and treatment approaches often fail to deliver total recovery to patients.

Identifying Better Diagnostic Tools

To identify, treat, and perhaps even prevent CSS, we need better diagnostic tools. Instead of relying completely on a patient’s description of his or her symptoms, we need objective bio-markers. Similar to the new way in which we diagnose and treat cancers, we should be able to employ genetic testing, metabolomic testing, protionomic testing, and imaging studies such as CT scans and MRIs, to diagnose the causes of chronic pain.

Encouraging Research & Collaboration

We must encourage collaboration among researchers and practitioners so we can identify a legitimate path to recovery. We also aim to educate patients and physicians about neuroinflammatory disease, so that together we can advocate for more focused research and effective medical care.

On February 9-11th, 2022, we be holding our upcoming conference titled: Autoimmune Encephalopathy Secondary to Infectious Disease: A New Perspective on the Pathogenetic Interaction of the Immune system, Infection, Stress and Chronic Disease.  

The program is jointly sponsored by the International Center for Interdisciplinary Studies of Immunology (ICISI) at Georgetown University Medical Center, The Foundation for Total Recovery, and The Kaplan Center for Integrative Medicine.

This will be a three day virtual conference, open to the medical community, the public and media. We will be hosting some of the top experts across multiple medical disciplines including epidemiology, autoimmune disease, gut microbiome, PANS/PANDAS, ME/CFS, sleep, the impact of environmental factors and childhood trauma on the risk of developing autoimmune disease, Lyme Disease and COVID-19 / Long Haul COVID and other neuroinflammatory diseases. To learn more about the conference, click here.


Mission Statement

We need to change our minds on how pain is viewed. By seeing pain as a symptom of neuroinflammation, we can better understand and help the millions who suffer from chronic pain and depression. More research into neuroinflammation is needed to diagnose, treat, and ultimately prevent a disease that causes pain for so many; but we are on the right path.
– ​Dr. Linda Watkins, Ph.D. Department of Psychology & Neuroscience; Center for Neuroscience
University of Colorado at Boulder.

The Foundation for Total Recovery seeks to provide support and find a cure for all who suffer with chronic neuroinflammatory disease manifesting as ME/CFS, chronic pain, post treatment lyme syndrome, PANS/PANDAS, neuropsychiatric disorders and COVID-19 long haul by:

  • Partnering with leading researchers, academics, and innovators
  • Studying and publicizing the latest data on neuroinflammation
  • Finding a baseline approach to diagnosing and curing neuroinflammatory disease manifesting as chronic illness
  • Educating patients and medical professionals about these diseases and the most effective treatments

As an 501c3 organization, all U.S. donations to the Foundation for Total Recovery are tax-deductible. You can make a tax-deductible donation here.